Liat Anafi

2.1k total citations
10 papers, 223 citations indexed

About

Liat Anafi is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Liat Anafi has authored 10 papers receiving a total of 223 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Immunology. Recurrent topics in Liat Anafi's work include RNA regulation and disease (2 papers), Systemic Lupus Erythematosus Research (2 papers) and Immune Cell Function and Interaction (2 papers). Liat Anafi is often cited by papers focused on RNA regulation and disease (2 papers), Systemic Lupus Erythematosus Research (2 papers) and Immune Cell Function and Interaction (2 papers). Liat Anafi collaborates with scholars based in Israel, Germany and Spain. Liat Anafi's co-authors include Iris Barshack, Michal J. Besser, Yael Nemlich, Gal Markel, Jacob Schachter, Ricard Cervera, Yehuda Shoenfeld, Eliezer Shalev, Mati Fridkin and Michael Blank and has published in prestigious journals such as Nature Communications, Scientific Reports and Journal of Hepatology.

In The Last Decade

Liat Anafi

10 papers receiving 218 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liat Anafi Israel 7 105 79 37 31 29 10 223
Peiqiang Li China 10 121 1.2× 69 0.9× 43 1.2× 59 1.9× 15 0.5× 21 300
Martina Tufano Italy 9 108 1.0× 92 1.2× 102 2.8× 27 0.9× 31 1.1× 19 264
Lisa Russell United States 8 86 0.8× 199 2.5× 54 1.5× 49 1.6× 47 1.6× 8 309
Gaurav Kumar United States 9 153 1.5× 59 0.7× 62 1.7× 8 0.3× 28 1.0× 10 314
Simona Tortorella Italy 8 185 1.8× 57 0.7× 107 2.9× 14 0.5× 61 2.1× 12 334
Yang Lyu United States 7 165 1.6× 48 0.6× 70 1.9× 14 0.5× 52 1.8× 31 287
Zhifu Xiang United States 7 176 1.7× 79 1.0× 76 2.1× 31 1.0× 35 1.2× 22 355
Susanne Diener Germany 6 47 0.4× 51 0.6× 44 1.2× 15 0.5× 13 0.4× 8 148
Anthony Liew United States 5 139 1.3× 114 1.4× 54 1.5× 60 1.9× 56 1.9× 7 270
Dong‐Chun Hong China 8 104 1.0× 50 0.6× 98 2.6× 20 0.6× 28 1.0× 15 226

Countries citing papers authored by Liat Anafi

Since Specialization
Citations

This map shows the geographic impact of Liat Anafi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liat Anafi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liat Anafi more than expected).

Fields of papers citing papers by Liat Anafi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liat Anafi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liat Anafi. The network helps show where Liat Anafi may publish in the future.

Co-authorship network of co-authors of Liat Anafi

This figure shows the co-authorship network connecting the top 25 collaborators of Liat Anafi. A scholar is included among the top collaborators of Liat Anafi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liat Anafi. Liat Anafi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Markovits, Ettai, Erez N. Baruch, Eldad D. Shulman, et al.. (2023). MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2. Cancer Immunology Research. 11(7). 909–924. 8 indexed citations
2.
Braun, Tzipi, Amnon Amir, Rakefet Ben-Yishay, et al.. (2023). Reduced LHFPL3-AS2 lncRNA expression is linked to altered epithelial polarity and proliferation, and to ileal ulceration in Crohn disease. Scientific Reports. 13(1). 20513–20513. 1 indexed citations
3.
Dadiani, Maya, Nora Balint‐Lahat, Liat Anafi, et al.. (2020). TNFR2+ TILs are significantly associated with improved survival in triple-negative breast cancer patients. Cancer Immunology Immunotherapy. 69(7). 1315–1326. 11 indexed citations
4.
Baruch, Erez N., Rona Ortenberg, Camila Avivi, et al.. (2020). Immune co-culture cell microarray – a feasible tool for high-throughput functional investigation of lymphocyte–cancer interactions. OncoImmunology. 9(1). 1741267–1741267. 2 indexed citations
5.
Anafi, Liat, et al.. (2019). Blastemal NCAM+ALDH1+ Wilms' tumor cancer stem cells correlate with disease progression and poor clinical outcome: A pilot study. Pathology - Research and Practice. 215(8). 152491–152491. 6 indexed citations
6.
Nemlich, Yael, Erez N. Baruch, Michal J. Besser, et al.. (2018). ADAR1-mediated regulation of melanoma invasion. Nature Communications. 9(1). 2154–2154. 38 indexed citations
7.
Kandel-Kfir, Michal, Tal Almog, Aviv Shaish, et al.. (2015). Interleukin-1α deficiency attenuates endoplasmic reticulum stress-induced liver damage and CHOP expression in mice. Journal of Hepatology. 63(4). 926–933. 32 indexed citations
8.
Galore-Haskel, Gilli, Yael Nemlich, Eyal Greenberg, et al.. (2015). A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme. Oncotarget. 6(30). 28999–29015. 54 indexed citations
9.
Blank, Miri, Ilan Krause, Nir Dotan, et al.. (2012). Anti-GalNAcβ: A novel anti-glycan autoantibody associated with pregnancy loss in women with antiphospholipid syndrome and in a mouse experimental model. Journal of Autoimmunity. 39(4). 420–427. 6 indexed citations
10.
Blank, Michael, Liat Anafi, Gisele Zandman‐Goddard, et al.. (2007). The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model. International Immunology. 19(7). 857–865. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026